Mount Sinai, one of the city’s largest hospital systems, is seeing improving operating margins at its flagship hospital, even ...

Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share what their system has done to expand their access to care. The 10 executives featured in this article are ...

To reduce readmission rates, hospitals must consider several factors such as standards for length of stay, medication management, and discharge planning, this new CMO says.

The largest Medicaid claims processor has built a network of at least 1,800 engineers and analysts in India, rapidly ...

President Trump is attempting to reshape America’s biotech industry with two primary objectives. He wants more medicines to ...

For far too long, these companies have used our nation’s drug supply chain to benefit shareholders and executives while ...

States tighten grip on PBMs Pharmacy benefit managers have been facing regulatory pushback in 2025, with new laws aimed at breaking up vertical integration and increasing pricing transparency.

The rejection of House Bill 3212 in the 2025 Oregon Legislative Session is causing concern for struggling pharmacies and ...

NY pharmacists say patients are struggling to find drugstores carrying key medicines as Rite Aid and other pharmacies close.

Oklahoma lawmakers passed HB 2048 to protect the 340B Drug Pricing Program, overriding a veto amid growing pressure from pharmaceutical interests.

Explore the lessons learned from 2024 in pharmacy benefits, including the impact of polypharmacy, biosimilars, and GLP-1 medications, and what to expect for 2025 in this insightful article.